Dose-escalated conformal radiotherapy is increasingly being used to radically treat prostate cancer with encouraging results and minimal long-term toxicity, yet little is known regarding the response of normal or malignant prostate cells to ionizing radiation (IR). To clarify the basis for cell killing during prostate cancer radiotherapy, we determined the IR-induced expression of several apoptotic-(bax, bcl-2, survivin and PARP) and G1-cell cycle checkpoint-(p53 and p21 WAF1/Cip1 ) related proteins, in both normal (PrEC-epithelial and PrSC-stromal) and malignant (LNCaP, DU-145 and PC-3; all epithelial) prostate cells. For these experiments, we chose doses ranging from 2 to 10 Gy, to be representative of the 1.8 -2 Gy daily clinical fractions given during curative radiotherapy and the 8 -10 Gy single doses given in palliative radiotherapy. We observed that IR-induced bax and p21 WAF1/Cip1 protein expression were attenuated selectively in normal stromal and epithelial cell cultures, yet maintained their p53-dependency in malignant cell lines. For each cell culture, we also determined total apoptotic and overall radiation cell kill using a short-term nuclear morphologic assay and a long-term clonogenic survival assay, respectively. Clonogenic survival, as measured by the surviving fraction at 2 Gy (SF2), ranged from 0.05 (PrEC) to 0.55 (DU-145), suggesting that malignant prostate cells are more radioresistant than normal prostate cells, for this series. IR-induced apoptotic cell kill was minimal (less than 6% cell after a dose of 10 Gy at times of 24 -96 h) and was not dose-dependent. Furthermore, apoptotic kill was not correlated with either molecular apoptotic response or clonogenic cell kill. Using a flow cytometric proliferation assay with the PrSC (stromal) and representative cultures, we observed that a senescent-like phenotype (SLP) emerges within a sub-population of cells post-irradiation that is non-clonogenic. Terminal growth arrest was dose-responsive at 96 h following irradiation and associated with long-term expression of both p21 WAF1/Cip1 and p16 INK4a genes. Future strategies for prostate radiotherapy prediction or novel treatments should additionally focus on terminal growth arrest as an important endpoint in prostate cancer therapy.
Introduction
Dose-escalated (ie 76 -80 Gy) radiotherapy is an important treatment option for men with intermediate-risk prostate cancer who present with T1 or T2 disease, a Gleason score greater than 6 out of 10 and serum prostatic specific antigen (PSA) values in the order of 10 -20 mg/ml. 1 Successful radiotherapy results in a gradual decline of the serum PSA over 12 -24 months following treatment where a PSA nadir of less than 1.0 mg/ml predicts for 5 year, long-term local control. 2 With three-dimensional conformal (3D-CRT) or intensity-modulated (IMRT) radiotherapy treatment protocols, 5 year PSA-free relapse rates are approximately 75 -85% and associated with minimal late toxicity (less than 5% with Radiotherapy Oncology Group (RTOG) Grade 3 -4 rectal or bladder damage). 2 Yet these same data predict that 15 -25% will not achieve local control following radical radiotherapy, thought in part to be due to the intrinsic radioresistance of prostate cancer cells secondary to genetic (eg apoptosis, cell-cycle or DNA-repair-related gene expression) or microenvironmental factors (eg hypoxia or altered growth factor expression). 3 The success of radiation therapy in prostate cancer treatment is therefore dependent on the eradication of all prostate tumor clonogens (ie tumor stem cells, estimated to be less than 1% of cells within a tumor), which are select tumor cells capable of unlimited proliferative potential. Failure to eradicate this particular population will result in the regrowth of the tumor following treatment. 4 Despite many advances towards understanding prostate carcinogenesis, little work has been published to date relating the mode of clonogenic cell kill following DNA damage in either normal and malignant prostate epithelial cell cultures. This information is important in defining new strategies to augment prostate cancer cell kill and understand the kinetics of cell kill following radiotherapy (in comparison to decreasing PSA value kinetics in vivo) and may allow optimal interpretation of post-radiotherapy biopsies as a secondary measure of local tumor control.
Apoptosis plays an important role in the death of both normal prostate and androgen-dependent malignant prostate tissue following androgen withdrawal, leading to a decrease in either glandular or tumor volume, respectively. This is supported by the observation of rapid apoptosis following castration in the rat prostate glands 5, 6 (a response lacking in mice deficient in expression of the pro-apoptotic gene, bax 7 ) and in patients treated with androgen-withdrawal therapy for locally advanced or metastatic prostate cancer. 8 The relationship between androgen ablation and apoptosis has led to a number of clinical studies that have attempted to determine whether local failure following radical radiotherapy is secondary to genetic factors that control radiationinduced apoptosis. However, taken together, clinicopathologic studies that have attempted to correlate altered expression of the p53, p21 WAF1/Cip1 , bax, bcl-2 and caspase apoptosis-related genes and radiocurability have been inconclusive. 9, 10 This may be due to small clinical sample size, differences in the quantitation or timing of immunohistochemical or gene expression endpoints, 11, 12 variable clinical treatment parameters, or perhaps due to alternate mechanisms of prostate cell death that confound analyses focused solely on apoptotic endpoints.
Recent data has supported the hypothesis that apoptosis may not be the dominant mode of cell death following radio-and chemotherapy in stromal (ie fibroblast) and epithelial tissues. 13, 14 Indeed, it has been suggested that in these and selected tumor models, apoptosis may actually occur in a non-clonogenic population following DNA damage. 15, 16 Alternatively, a permanent cell-cycle arrest or senescence-like terminal growth arrest may also be a factor in determining prostate cell death following radiotherapy. 17 Markers of senescence, such as senescence-associated b-galactosidase (SA b-gal) activity and permanently elevated levels of p21 WAF1/Cip1 and p16 INK4a are actively under investigation as biomarkers of terminal growth arrest in human tumors. 18 Chang and co-workers 19 observed that a number of DNA-damaging agents (including ionizing radiation) could induce a senescencelike phenotype (SLP) in 11/14 cell lines tested. Other laboratories 13 and reviews have outlined a number of considerations regarding radiation-induced cell-death, including cell-type dependency in defining the dominant mode(s) of death (ie apoptosis, mitotic-linked death and reproductive death (SLP)/necrosis). 20 An improved understanding of death processes has been afforded by novel flow cytometric methods to detect terminallyarrested tumor cells following drug treatment, 19, 20 and ascertain their relative morphology and clonogenic potential.
The purpose of the current study was to examine the mode(s) of prostate cell death in vitro following exposure to ionizing radiation to possibly refine clinical biomarkers for prediction of radiotherapeutic response and suggest future treatment strategies. Apoptosis, proliferation and clonogenic survival were assessed in a panel of cell lines comprised of both normal (stromal-PrSC and epithelial-PREC) and malignant (LNCaP, DU-145, PC-3; all epithelial) cultures, to determine the overall cellular response. We demonstrate that apoptosis is not the dominant mode of cell kill in this panel of cell cultures post-IR. Instead, data on selected cell lines supports the concept that longterm proliferative arrest relates to clonogenic radiation cell killing in vitro.
Materials and methods

Cell culture
All cell cultures were incubated in vented tissue culture flasks under 5% CO 2 and 37 C culture conditions. LNCaP cells (a gift from L Chung, University of Virginia) were maintained in T-media (Gibco-BRL) and supplemented with 10% FCS. PC-3 and DU-145 cells were purchased from ATCC and maintained as suggested in Ham's F12K, and alpha-Modified Eagles Medium respectively, supplemented with 10% FCS and 2 mM L-glutamine. PrEC (normal prostate epithelial cells) and PrSC (normal prostate stromal cells) were purchased from Clonetics and maintained as per suggested protocol in PrEGM media and SCGM media, without testosterone supplementation, respectively. Both cell cultures have limited lifespan and proliferative potential in culture according to the supplier and we have consistently observed decreased growth rates following passage 5 in vitro for both cultures. Immortalized myc-infected Rat-1 HO15.19 fibroblast cells (a gift from Dr L Penn, OCI/PMH 21 ) were maintained in Dulbecco's H21 media supplemented with 10% FBS. Cultures were maintained without testosterone supplementation to ensure that radiation survival studies were completed under similar conditions in normal and malignant prostate cultures and as previous experiments have determined that exogenous testosterone may not always alter apoptotic responses, clonogenic survival or IR-induced p21 WAF1/Cip1 expression and cell arrest in androgen-sensitive cells ( J Tsihlias, personal communication 22, 23 
SF2Gy and clonogenic radiation survival curves
Logarithmically growing cells were rinsed with PBS/ HBSS, trypsinized for 5 min at 37 C, and then were seeded at appropriate densities for colony formation in six-well dishes (Nunc). Asynchronous cultures were irradiated 16 -20 h post-plating to reduce the immediate effects of trypsinization and such that the multiplicity index was less than 1.1. 24 At least two dilutions of cells in triplicate were used for each dose point for any given individual experiment. At least three independent clonogenic radiation experiments were completed for each cell line. Plated cells were either mock irradiated or irradiated with 0 -10 Gy under aerobic conditions using a 137 Cs irradiator at $1 Gy/min at room temperature. Plates were then incubated at 37 C for 7 -14 days depending on cell doubling time in vitro and re-fed every 4 -5 days before fixation and staining (methylene blue/50% methanol) of resulting colonies (aggregates of greater than 50 cells were scored as a colony). Radiation survival was calculated as the plating efficiency of treated cells divided by the plating efficiency of untreated cells and plotted as a function of dose on a semi-logarithmic plot as previously described. 24 We were unable to derive colonies at doses greater than 2 Gy in the LNCaP and PrEC cell cultures due to poor plating efficiencies, and therefore only SF2 values are presented for these cultures. For a given cell culture, there was no correlation between the SF2 values and plating efficiency amongst individual experiments, although mean SF2 values were increased in cell lines which exhibited increased plating efficiency, as reported in the literature (ie DU-145 and PC-3). 3, 21 Western blotting
Logarithmically-growing cells were irradiated and lysed on ice for 20 min with E7 lysis buffer as previously described. 24 Protein quantification was performed determined using a commercial Pierce-BCA assay kit to derive a mean concentration value based on three assays per lysate. SDS -PAGE was performed using 7 -12% bisacrylamide (29:1) gels with a 4% stacking gel run in a Novex X-cell semi-dry Mini Cell western blotting apparatus at room temperature. Each well was loaded with 20 mg of total protein plus loading buffer (final concentration 1Â76% glycerol, 0.83% b-mercaptoethanol, 1.71% Tris-HCl pH 6.8, 0.002% Bromophenol Blue) after boiling for 3 min. Samples resolved by electrophoresis at 80 -110 V for 1.5 -2.5 h were transferred onto nitrocellulose overnight at 14 V/4 C or for 1.5 h at 24 V/room temperature in transfer buffer (75 mM glycine, 10 mM Tris, 20% methanol). For selected blots, pre-hybridization staining with Ponceau S confirmed equal loading and transfer between running lanes.
To detect protein, membranes were blocked in TBST/ 0 -10% low fat milk and then exposed to the primary antibody 2 -4 h at room temperature constant rotation. Membranes were then rinsed with TBST and exposed to the appropriate secondary antibody for 1 h under similar conditions, rinsed again with TBST, once with 10Â TBS and finally incubated in Amersham ECL chemiluminescence solution for 1 min. Membranes were exposed to Hyperfilm ECL from AmershamPharmacia and analyzed by densitometry (Molecular Dynamics Computing Densitometer, ImageQuant Mac version 1.2). Primary antibodies used in these studies included: p53-mouse monoclonal (Santa Cruz Bp53-12, 1:3000); p21 WAF1 -mouse monoclonal (Oncogene Ab-1, 1:3000); Bax-rabbit polyclonal (Santa Cruz N-20, 1:1000); Bcl-2-mouse monoclonal (Santa Cruz 509, 1:500); PARP-mouse monoclonal (BioMol SA-249, 1:1000), survivin-rabbit polyclonal (Alpha Diagnostics SURV11, 1:5000), and p16 INK4A mouse monoclonal (Oncogene Ab-1, 1:1000).
Assays for apoptotic cell death
Radiation-induced apoptosis was quantified on the basis of distinct nuclear morphology and associated apoptotic bodies based on a previously standardized immunofluorescence protocol (Hoechst 33342 staining). 24 For the morphology assay, logarithmically growing cells were re-plated at appropriate densities in triplicate and mock/irradiated with 0, 2, 10 or 20 Gy. These were scored for apoptotic morphology (ie apoptotic bodies and nuclear condensation -see sample in Figure 2a Radiation survival in proliferating and non-proliferating irradiated cultures: the CFDA-SE flow cytometry proliferation assay
To determine if permanent arrest is associated with decreased clonogenic survival, a modification of the protocol by Chang et al 19 utilized the CFDA-SE (CFSE) fluorescent dye. 20, 26 The CFSE compound (Molecular Probes, C-l157) is distributed throughout the cellular membranes and is divided evenly amongst subsequent progeny based on division of equal volumes of membrane at cell division. Multiple rounds of cell division are therefore represented by a corresponding decrease in total membrane fluorescence within a proliferating population, which can be detected by flow cytometry. Analyzing cell populations for relative fluorescence (FL1 (CFSE) parameter; increased non-proliferating cultures) and increasing side-scatter (SSC parameter; due to increased granularity associated with senescent cells) allows for flow cytometric analysis of senescent-like populations post-treatment.
Sub-confluent flasks of cells were trypsinized, collected and centrifuged into a pellet and 5 6 10 6 cells were resuspended in 1 ml serum-free media plus 1 ml of stock solution (5 M CFSE in DMSO) at 37 C for 10 min with occasional inversion. Ice-cold RPMI 1640 þ 10% FBS was then added prior to a subsequent cell centrifugation, and finally the cells were re-suspended in PBS. The cells were further washed twice in PBS, re-plated at low density (approximately 10% confluence) into multiple, 175 cm 2 Falcon flasks for next-day irradiation (0 -10 Gy). As a control, all cells (floating and adherent) from one untreated flask were harvested one day post-plating and analyzed with flow cytometry to find baseline fluorescence (FL1(CFSE)) intensity. Remaining cultures were followed until day 5 when all cells (floating and adherent) were harvested, analyzed and sorted by FACS into 'nonproliferating' (FL1(CFSE) hi SSC hi ), and 'proliferating' (ie all cells other than FL1(CFSE) hi SSC hi ) populations to determine clonogenic potential within each population. The 5 day time point was initially chosen as it represents the point at wbich surviving cells would begin to show their colony-forming ability. 3 Sorted populations of DU-145 and PrSC were used to derive colonies in each sub-group as examples of epithelial and stromal (ie fibroblast-like) models. Pre-sort samples were analyzed on a BDIS FACScan analyzer and samples sorted using either a Becton Dickonson Immunocytometry system FACStarPLUS or BDIS FACS Vantage system. BDIS CELLQuest Software version 3.3 was used for both sorting and analysis. Cell lysates from adherent and floating cells in parallel cultures treated similarly (stained, irradiated with 0, 2 and 10 Gy) were also harvested on days 5 -9, and analyzed for expression of the p16 INK4a and p21 WAF1 genes. Cultures were also stained for senescence-associated b-galactosidase (SA b-gal) using the method of Chang et al, 19 as a complementary biomarker of senescence-like death.
Results
Gene expression of apoptosis-related genes within irradiated prostate cell cultures
As different laboratories may contain variants of original cell stocks, we initially determined the p53 status of the malignant prostate epithelial cell lines using full-length DNA sequencing of exons 1 -11 of the p53 gene. Consistent with previous reports, LNCaP cells were found to express two wild-type (WT) alleles, whereas the PC-3 cells were devoid of p53 protein expression due to chromosome 17p hemizygosity and a mutation in the remaining allele at codon 138 which results in a premature stop codon at position 169. The DU-145 cells express mutant (MT) p53 protein due to mutations at codons 223 and 274. We observed that the level of bax protein expression is p53-dependent following IR, given the increased expression in the WTp53-expressing LNCaP cells at 24 h following 10 Gy. This molecular response was attenuated, or absent, in the remaining PC-3 and DU-145 malignant epithelial cell lines, which have altered p53 protein expression. Of note, despite the western blots shown in Figure 1b , bax expression is detectable in DU-145 cells, albeit at a very low level. The response was also attenuated within the normal epithelial and stromal cultures (see Figure 1a , b and Table 1 ). Bcl-2 protein levels were low, yet detectable, using our antibody, and remained unchanged in all cell cultures following 10 Gy for periods up to 24 h following radiation (see Figure 1c, d) . In other experiments in our laboratory, the relative levels of bax and bcl-2 protein have been confirmed at the mRNA level by RNA protection analyses (R Fan and RG Bristow, manuscript in preparation). The IAP-related protein, survivin, has been suggested to be a prognostic indicator in a variety of cancers, presumably due to its influence on cellular apoptosis and G2 phase cell cycle control 27 and reported differential upregulation in malignant tissues, relative to normal tissues. 28 In vitro, endogenous survivin levels were observed to be detectable in all of the cell cultures within our series (normal and malignant), and were invariant following irradiation (Table 1) except for a slight (1.6-fold) increase in PrSC. Subsequent experiments have revealed lower levels of survivin in PrEC cultures than in their stromal and malignant counterparts.
Terminal apoptotic transduction involves altered expression and cleavage of the caspase family of proteins and the PARP protein. 29, 30 Other laboratories have reported that caspase 1 and 3 protein expression can be deficient in some of our malignant cell lines. 31 In our experiments, analysis for PARP cleavage revealed that, although we detected an increase in the characteristic 89 kD a apoptotic-related PARP protein fragment in our highly apoptotic Rat-1 HO15.19 cell line, there was no such change in any of the five prostate cell cultures at 24 h following a dose of 10 Gy (data not shown). Our results (summarized in Table 1 ) suggest that gene and protein expression related to terminal apoptosis-defining events following IR is not consistent with observations made for other cells (eg lymphocytes or thymocyctes), which are classically more susceptible to radiation-induced apoptosis; however we recognize that the molecular apoptotic and morphologic (see below) response of our cell panel may be variable, depending on type of cell stress and drug treatment.
Minimal evidence of apoptotic cell death in irradiated prostate cultures
We next determined the level of radiation-induced apoptosis following various doses (2 -20 Gy) and time points (0 -96 h post-IR) using a distinct nuclear morphology assay (see Figure 2a) as previously described. 24 A dose of 10 Gy has been shown to decrease clonogenic survival by 3 logs or more, in other malignant cell lines. The highly apoptotic adherent Rat-1 HO15.19 cell line formed a positive control for IR-induced apoptosis in these experiments and irradiated cultures were observed to contain decreasing numbers of cells over 24 -96 h consistent with a rapid induction of cell death (data not shown). The level of apoptosis in Rat-l HO15.19 control following 20 Gy became difficult to quantify at 24 h due to a large amount of cellular debris and may be underestimated, as presented in Figure 2b . The apoptotic response of our prostate cell panel at times of 24 -96 h following 10 Gy as determined by morphology is presented in Figure 2b , and reveals that neither normal nor malignant prostate cells undergo high levels of apoptosis at any time point up to 96 h (a time at which the earliest colonies indicative of clonogenic survival can be detected). Additionally, careful total cell counts of adherent and floating cells within all the irradiated cultures suggested that there was no decrease at any time point up to 96 h in total cell number, which ruled out underestimating apoptotic responses (data not shown). Moreover, in contrast to the Rat-1 HO15.19 Myc-expressing control, there was no evidence for a dose-dependent increase in apoptosis in our panel of cultures (2 Gy range ¼ 0 -1%, 10 Gy range ¼ 0 -6%, 20 Gy range ¼ 0 -3%; see Figure 2c ).
We observed a trend towards increased levels of apoptosis among the malignant cell lines as compared with the normal cell cultures, although these relative differences were not consistent. The data presented using the in vitro morphology assay was also supported by the absence of an apoptotic sub-G1 29 peak within DNA histograms of irradiated PC-3, DU-145 and LNCaP cells using flow cytometry, the lack of apoptotic morphology post-IR of the same cells as analyzed by the COMET DNA-damage assay, 32 and minimal TUNEL staining of the PC-3 cell line either in vitro or in vivo (growing as a xenograft i.m., in a nude mouse host) following irradiation (data not shown). These results suggest that cellular apoptosis is not a major mechanism of IR-induced prostate cell death under the culture and treatment conditions used in this study. Low, barely detectable, no change post-XRT; $ less than 2-fold change; : greater than 2-fold increase; :: greater than 4-fold increase (quantified using relative densitometry).
Molecular analysis of checkpoint control in prostate cells
The p53 status in normal and malignant cells can be functionally related to either apoptosis or a G1 and G2 cell cycle arrest or checkpoint, and dependent on cell type, level of DNA damage or cell stressor. 33, 34 We therefore confirmed the presence or absence of a molecular p53-dependent G1 checkpoint in the normal and malignant prostate cells by determining the IR-induced upregulation of the cdk-inhibitory protein, p21 WAF1/Cip1 . Following IR-induced DNA damage, the p53 protein is stabilized post-transcriptionally, by alternate phosphorylation of its amino terminus at serine residues 15 and 20 through both direct and indirect actions of the ATM protein. Stabilized p53 protein can then lead to a transcriptional upregulation of the p21 WAF1/Cip1 protein, which inhibits the G1 cyclin-cdk kinase complexes, and results in a G1 arrest secondary to hypo-phosphorylation of the pRB (retinoblastoma) protein. An increased level of p53 protein was observed following irradiation in all WTp53-expressing prostate cells and peaked at 2 -6 h following IR-treatment ( Figure 3 ). As expected, we observed a lack of p53 protein expression in irradiated null-p53 PC-3 cells and elevated endogenous levels of p53 protein in the MTp53-expressing DU-145 cells (consistent with a longer half-life for the MTp53 protein; Figure 3b ), which were invariant post-IR. The PrEC and PrSC normal cultures both showed similar stabilization of the p53 protein relative to a-tubulin levels following irradiation. However, in the PrSC cells, the p21 WAF1/Cip1 levels were upregulated and sustained at 24 h; in the PrEC cells, the response was relatively attenuated in level and was duration reaching almost pre-irradiation levels at 24 h (Figure 3a) . We failed to observe an increase in p21 WAF1/Cip1 expression in the MTp53-expressing and null-p53 cell lines (DU-145 and PC-3 respectively), 35 however the WTp53-expressing LNCaP cell line did show a strong IR-induced upregulation of p21 WAF1/Cip1 . 
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The p53 and p21 WAF1/Cip1 protein expression results were correlated to relative mRNA levels under similar culture conditions using RNA protection analyses in separate experiments (R Fan and RG Bristow, manuscript in preparation). These data support the idea that p53 can induce a molecular G1 checkpoint in both normal and malignant prostate epithelium, but highlights previous observations that, in certain normal epithelial cultures, p21 WAF1/Cip1 expression may be attenuated relative to stromal cultures 36 in a tissue-specific manner. This may relate to relative control of cell-cycle related checkpoint and carcinogenesis in these two tissues. 37
SF2Gy and clonogenic survival for normal and malignant prostate cultures
Colony-formation after DNA damage measures the longterm survival of cells that are capable of unlimited proliferation and summarizes all types of IR-induced modes of cell death including apoptosis, mitotic-linked death (death after two or three aborted divisions followed by apoptosis or necrosis) and permanent growth arrest leading to necrosis. 33 Consistent with selected reports, 38,39 full clonogenic survival curves could not be generated for our LNCaP cell line, due to poor plating efficiencies, which made determination of colony-formation at doses greater than 2 Gy difficult. We encountered similar difficulties with PrEC normal epithelial cultures, which also had a poor plating efficiency (0.1 -1%). Nonetheless, for all cell lines we were able to generate radiation survival data after a low, clinically relevant dose of 2 Gy (SF2), which approximates the daily fraction of radiation within curative radiation protocols. Full clonogenic survival curves following doses up to 10 Gy (a dose approximating a single-fraction palliative treatment) were derived for the PC-3, DU-145, PrSC and Rat-1 HO15.19 cell cultures and the results are plotted in Figure 4a . The SF2 values for all cell cultures are shown in Figure 4b . The normal stromal and epithelial cultures were the most radiosensitive based on SF2 values, even though they had the lowest levels of IR-induced apoptosis at similar doses. Furthermore, the apoptotic kill response in the DU-145 and Rat-l HO Myc cell lines was quite disparate, despite similar clonogenic survival (see Figure 2b ,c). We observed that the DU-145 and PC-3 cell lines with altered p53 status were more radioresistant than the WTp53-expressing LNCaP cell line. However, defined experiments with prostate cell lines that are isogenic save for p53 status are required before concluding that p53 status correlates with radiosensitivity in prostate cancer cells. In summary, we have observed that the overall level of apoptosis was not correlated to the overall level of clonogenic cell survival in our panel of cell lines. Plotting the relative cell kill following 2 and 10 Gy based on the two endpoints in Figure 4c illustrates the discrepancy between the results of two assays.
Permanent arrest in irradiated prostate cells
Given that apoptosis was not a dominant mechanism for clonogenic cell kill, we next investigated the contribution of terminal growth arrest associated with senescenceassociated markers to clonogenic survival using both a representative stromal culture (PrSC cells), and a representative epithelial culture (DU-145 cells). The choice of these two cultures was predicated on the need for cell lines which would readily form colonies following flow cytometric sorting procedures at 2 and 10 Gy and to Death in irradiated prostate epithelial cells GP Bromfield et al maximize the tissue-specific and genetic differences relating to propensity for senescence, clonogenic cell kill and G1 checkpoint control. Using a flow cytometric assay that simultaneously determines relative levels of FL1-CFSE fluorescence (ie proliferation) and SSC-parameter (cell granularity), we determined that up to 87% of the PrSC population was non-proliferating with an associated increased granularity (FL1(CFSE) hi SSC hi ) at 5 days, following a dose 10 Gy of radiation. In similarly plated cultures, only 14 and 8% showed the same cytometric profile in 2 Gy-treated or control cultures; these relative proportions being consistent over two or three representative experiments (Figure 5a, c) . By comparison, only 32% of DU-145 cells had a senescent-like cytometric profile, although upon closer inspection the data suggest that the vast majority (ie greater than 70%) of DU-145 cells were actually nonproliferating, but that these cells were inconsistently associated with increased granularity when compared with stromal PrSC cells (compare CFSE-fluorescence axis in both cell lines following 10 Gy in Figure 5 ). The FL1(CFSE) hi SSC hi cytometric profile was determined for 5% of DU-145 cells following 2 Gy and 3% in the untreated DU-145 population (Figure 5a , b; note that cells not growth-arrested following 2 Gy or in nonirradiated cultures may have undergone multiple rounds of division by this point differentially increasing the total 'proliferating' population). We then sorted and plated cells from the senescent-like, non-proliferating population relative to the remaining cells and observed that relative colony forming ability (plating efficiency) was decreased in the FL1(CFSE) hi SSC hi ('non-proliferating'), SLP population in a dose-responsive manner (see Table 2 ).
In normal fibroblasts (ie stromal cells), cells undergo decreasing proliferative potential with increasing passage in vitro, until finally undergoing senescence associated with increased granularity, positive SA b-gal staining and upregulation of the p21 WAF1/Cip1 and p16 INK4a proteins. Similar changes occur in normal fibroblast cultures when exposed to IR and has been referred to as a 'premature IRinduced senescence'. 40 -42 Although we observed greater SA b-gal staining intensity in an increased number of PrSC stromal cells following a dose of 10 Gy (see Figure 6a) , we found the endpoint to be highly variable across all cell lines and difficult to quantitate in epithelial cells (further data not shown; noted by others 43 ). Whether upregulation of one or both genes is absolutely required for senescence and whether the process is p53-dependent in all cell types remains controversial.
In order to determine whether similar gene expression changes occurred in PrSC and DU-145 cells, we performed western blot analyses of cell populations obtained in parallel with flow cytometric experiments at day 5. These analyses showed high, IR-invariant levels of p16 INK4a protein in both PrSC and DU-145 cultures and a dose-dependent increase in p21 WAF1/Cip1 levels in PrSC cells only (Figure 6b ; confirmed using densitometry). We also analyzed p16 INK4a expression in all of the cell cultures at 24 h following 10 Gy. In this case, levels of p16 INK4a were either invariant (PrEC, LNCaP, DU-145) or undetectable (PrSC, PC-3) as confirmed by relative densitometry (data not shown). Long-term (up to 9 days) analysis of p16 INK4a expression post-10 Gy irradiation DU-145 and PrSC demonstrated increasing expression with time (data not shown), suggesting a timedependent, though not dose-dependent, expression of p16 INK4a . We conclude that cells within a terminally arrested population that have increased cellular granularity (SLP) are incapable of forming colonies and that the sub-population of proliferating cells without associated increased granularity defines the colony-forming potential of the entire irradiated culture. hi SSC hi fractional sub-population (representing a senescent-like phenotype) with increasing dose; similar cytometric data was observed in all replicate experiments. These populations as shown were sorted using flow cytometry to determine relative colony forming ability as tabulated in Table 2 .
Discussion
This is the first report, to our knowledge, documenting the relative role of apoptosis and terminal growth arrest as factors in determining overall clonogenic radiation cell survival for a panel of normal and malignant prostate cell cultures within the same laboratory setting. Using clinically relevant radiation doses, we observed a strong molecular apoptotic response in certain cell lines (bax and p53 upregulation in LNCaP cells, post-IR), yet this response did not correlate with quantitative determinations of apoptosis using morphology endpoints. The apoptotic response was not dose-responsive and did not correlate with final clonogenic cell kill. Further support for our data are the observations that manipulation of the ceramide-sphingomyelin and bcl-2-associated apoptotic pathways, or androgen ablation, can increase the apoptotic responses of prostate cells without altering final clonogenic radiation survival (K Shim and RG Bristow, unpublished observation 22, 23, 44 ). Many groups have indicated that apoptosis may be the primary mode of death following gamma-irradiation only in specific cell types such as hematopoetic or lymphocytic cells, but not in stromal-or epithelial-derived tissues. 16,44 -47 Furthermore, many attempts to alter apoptotic indices in epithelial-and stromal-derived tissues have failed to affect clonogenic survival. This suggests that, although the apoptotic pathway is intact in malignant prostate cells, other death mechanisms may override this response following irradiation.
It has been suggested that epithelial cell G1 checkpoint may be abrogated or less efficient than that of its stromal counterpart, despite wild-type p53 status. Girinski et al 36 found an abrogated p21 WAF1/Cip1 induction and G1 checkpoint in a panel of normal prostate epithelial cells as compared to a panel of normal prostate stromal cells following ionizing radiation. Meyer et al 48 reported similar findings for mammary epithelial vs stromal tissues. Within the same group, Romonov et al 49 observed an abrogated response to replicative crisis in the mammary epithelial cells suggesting a global defect in epithelial response to stress in comparison to its stromal counterpart. Our own experiments illustrated that, even for similar levels of p53 induction/stabilization, the p21 WAF1/Cip1 response in PrEC is greatly attenuated in comparison to its stromal counterpart. While the p53/ p21 WAF1/Cip1 responses for our panel of malignant cell lines were as previously reported, the LNCaP cell line's 52 and cellular survival following radiation. 53 Indeed, although our results suggest increased survival for cells which lack the G1 checkpoint, defined studies in isogenic tissue culture or solid tumor models which differ in p53 status and specific G1, S and G2 checkpoint control experiments are required to prove this hypothesis, and are part of a current research program. 11 The success or failure of radical radiotherapy depends on the daily proportionate killing of tumor clonogens, which make up less than 1% of the total population of cells within a tumor. For example, it has been estimated that each gram of tumor contains approximately 1 6 10 9 tumor cells, with approximately less than 1 6 10 7 cells having clonogenic capacity. To date, no formal test or data exists for the pre-treatment determination of the number of clonogens existing prior to prostate radiotherapy. One can estimate that for a radiotherapy protocol using 35 -40 fractions of 2 Gy, the clonogenic SF2 value should be less than 0.60 (ie death after 35 treatments ¼ 0.6 35 ¼ 1.7 6 10 78 ) to cure a 1 g tumor, assuming equal killing per radiotherapy fraction. 4 Our data suggests that the SF2 in vitro is less than 0.6 for the cell lines tested. However, the effective SF2 may be higher in vivo, due to cell -cell interactions, hypoxia, altered gene expression or cell cycle phase during irradiation 3 and the relative importance of these factors remains to be determined in radiotherapy cohorts. Our observed in vitro radiosensitivity of normal epithelial and stromal cultures in vitro may explain the observation of glandular atrophy, fibrosis and decreased glandular function observed in prostate glands following irradiation. Exquisite sensitivity of normal epithelial cells may also explain why final posttherapy nadir PSA values in patients who achieve local control are lower than the PSA values in men without a diagnosis of prostate cancer, reflecting residual normal gland function after IR-induced cell kill. 54 In our experiments, relative clonogenic cell kill was approximated by quantitative endpoints of a dose-responsive terminal growth arrest, in which certain cells acquired a senescent-like phenotype. Terminal growth arrest, rather than apoptosis, may begin to explain the slow kinetics of decreasing PSA values following radiotherapy over 12 -16 months following treatment. 2 Recent experiments by Pollack and colleagues 23, 55 are consistent with our data, as the supra-additive radioresponses observed in LNCaP and Dunning rat R3327-G tumor models following combined androgen withdrawal and fractionated radiation (mimicking clinical stage T3-T4 prostate cancer treatment protocols which increase overall patient survival). 56 were secondary to factors which determined post-treatment cellular growth arrest rather than apoptosis.
If a surrogate measure of radiation sensitivity was developed to use prior to, or early during, the course of radiotherapy, specific measures could be used to increase radiocurability or abort radiotherapy altogether in favor of radical prostatectomy (if medically feasible). Crook et al 57 found that markers of proliferation (PCNA, MIB-1) in postradiotherapy biopsies from 498 men were an independent indicator of treatment failure, but indeterminate biopsies do occur which complicate interpretation as to whether viable clonogenic cells remain 2 -2.5 y following radical radiotherapy. Our data suggests that other surrogate predictive factors might include molecular or cellular senescence or cell cycle arrest factors, such as the cdk inhibitors, p21 WAF or p16 INK4a that are activated by DNA damage and lead to altered proliferation and terminal growth arrest.
At present, no predictive test can determine which cells in the tumor are prostate clonogens rather than non-clonogens, however we believe that terminal growth arrest should be further investigated as a major mechanism of cell death in addition to apoptosis, in protocols that utilize radiotherapy. If proven to be important in prostate cancer, the former mechanism of cell death might be augmented in vivo using radiotherapy in conjunction with inhibitors of prostate cancer cell proliferation such as retinoic acid, antisense to cdk inhibitors, inhibitors of telomerase, or inhibitors of histone deactylase (HDAC). 58, 59 Indeed these agents are currently being prospectively tested as single agents or in combination with chemotherapy in phase I/II trials; our results suggest further studies of the efficacy of these agents in combination with radiation as a novel prostate treatment strategy are necessary.
